Category News

ICVS Researcher Filipa Antunes Wins ART 3R Award for Innovative Parkinson’s Therapy

Filipa Antunes, a researcher at ICVS, has won the ART 3R Award for 2025. Her project, "Intranasal Administration as a Minimally Invasive Alternative for Stem Cell-Based Parkinson’s Disease Therapy in Rodents," has been awarded a €3,000 grant to explore a more humane and cost-effective method for treating Parkinson’s disease in animal models.

Read MoreICVS Researcher Filipa Antunes Wins ART 3R Award for Innovative Parkinson’s Therapy

ICVS Researchers Join Innovative GALActIC Study to Combat IAPA

ICVS is a contributing partner in the launch of GALActIC, a pioneering European Union research project aimed at tackling Influenza-associated Pulmonary Aspergillosis (IAPA). The study, led by a European consortium, is funded by the European Partnership for Personalised Medicine (EP PerMed) and promises to pave the way for more effective identification and treatment of this severe condition.

Read MoreICVS Researchers Join Innovative GALActIC Study to Combat IAPA

ICVS and INL Researchers Develop New Electrical Stimulator to Boost Cell Research

Researchers from ICVS and INL have developed an innovative multi-channel electrical stimulator designed to advance in vitro cellular research. This innovative device enables precise electrical stimulation of cells, promoting axonal growth and guiding stem cell differentiation, key processes in regenerative medicine and therapy development.

Read MoreICVS and INL Researchers Develop New Electrical Stimulator to Boost Cell Research

Tiago Gil Oliveira Wins 2024 BIAL Clinical Medicine Award

ICVS researcher Tiago Gil Oliveira has been awarded the 2024 BIAL Clinical Medicine Award for his groundbreaking work in Alzheimer's disease research. His project, titled “Unveiling the Mysteries of the Brain’s Regional Susceptibility to Neurodegeneration in Alzheimer's Disease: From Neuropathology to Brain Magnetic Resonance Imaging,” identifies the specific regions of the brain most affected by Alzheimer's, offering hope for earlier diagnosis and more effective treatments.

Read MoreTiago Gil Oliveira Wins 2024 BIAL Clinical Medicine Award

ICVS Researchers Receive Funding of “Fundação Bial” to Study Key Neural Mechanisms

Three researchers from ICVS were awarded funding by “Fundação Bial” of €60,000 each to carry out their research projects in neuroscience. The financial support will fund projects investigating the role of neural circuits in learning, memory, and cognitive flexibility, with a total funding amount of approximately €180,000.

Read MoreICVS Researchers Receive Funding of “Fundação Bial” to Study Key Neural Mechanisms